Gene Expression Signatures of Peripheral Blood Mononuclear Cells during the Early Post-Transplant Period in Patients Developing Cardiac Allograft Vasculopathy
Authors:
Open Access
- 28 December 2010
- journal article
- research article
- Published by Wiley in Journal of Transplantation
- Vol. 2010, 1-13
Abstract
Background. Cardiac allograft vasculopathy (CAV) is a major cause of graft loss and death after heart transplantation. Currently, no diagnostic methods are available during the early post-transplant period to accurately identify patients at risk of CAV. We hypothesized that PBMC gene expression profiles (GEP) can identify patients at risk of CAV.Methods. We retrospectively analyzed a limited set of whole-genome PBMC microarrays from 10 post-transplant patients who did () or did not () develop advanced grade CAV during their long-term follow-up. We used significance analysis of microarrays to identify differentially expressed genes and High-Throughput GoMiner to assess gene ontology (GO) categories. We corroborated our findings by retrospective analysis of PBMC real-time PCR data from 33 patients.Results. Over 300 genes were differentially expressed (FDR < 5%), and 18 GO-categories including “macrophage activation”, “Interleukin-6 pathway”, “NF-KappaB cascade”, and “response to virus” were enriched by these genes (FDR < 5%). Out of 8 transcripts available for RT-PCR analysis, we confirmed 6 transcripts (75.0%) including FPRL1, S100A9, CXCL10, PRO1073, and MMP9 ().Conclusion. Our pilot data suggest that GEP of PBMC may become a valuable tool in the evaluation of patients at risk of CAV. Larger prospectively designed studies are needed to corroborate our hypothesis.
Keywords
Funding Information
- National Institutes of Health
This publication has 36 references indexed in Scilit:
- New-onset graft dysfunction after heart transplantation—incidence and mechanism-related outcomesThe Journal of Heart and Lung Transplantation, 2011
- Unexplained Graft Dysfunction after Heart Transplantation—Role of Novel Molecular Expression Test Score and QTc-Interval: A Case ReportCardiology Research and Practice, 2010
- Methodological Challenges of Genomic Research—The Cargo StudyAmerican Journal of Transplantation, 2006
- Noninvasive Discrimination of Rejection in Cardiac Allograft Recipients Using Gene Expression ProfilingAmerican Journal of Transplantation, 2005
- Interleukin-6 Polymorphism: A Genetic Risk Factor for Cardiac Transplant Related Coronary Vasculopathy?The Journal of Heart and Lung Transplantation, 2005
- Detection of cardiac allograft rejection by real‐time PCR analysis of circulating mononuclear cellsClinical Transplantation, 2004
- Surrogate Markers for Late Cardiac Allograft SurvivalAmerican Journal of Transplantation, 2004
- A20 Protects From CD40-CD40 Ligand-Mediated Endothelial Cell Activation and ApoptosisCirculation, 2003
- Myocardial Ischemic Injury After Heart Transplantation Is Associated With Upregulation of Vitronectin Receptor (α v β 3 ), Activation of the Matrix Metalloproteinase Induction System, and Subsequent Development of Coronary VasculopathyCirculation, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001